Clinical Trials Directory

Trials / Completed

CompletedNCT04398979

Surgical Ablation for Atrial Fibrillation

Minimally Invasive Surgical Ablation for Standalone Atrial Fibrillation

Status
Completed
Phase
Study type
Observational
Enrollment
300 (actual)
Sponsor
Nanjing Medical University · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers

Summary

Minimally invasive approaches for surgical treatment have been advocated as a treatment option for stand-alone atrial fibrillation (AF). This study will investigate the clinical outcomes after minimally invasive surgical ablation of both paroxysmal and persistent/longstanding persistent AF.

Detailed description

Atrial fibrillation (AF) patients with a previous stroke are often at a high risk of recurrent stroke and bleeding. Minimally invasive approaches for surgical treatment have been advocated as a treatment option for stand-alone AF. This study will investigate the clinical outcomes after minimally invasive surgical ablation of both paroxysmal and persistent/longstanding persistent AF. Neurological safety will be assessed by cerebral magnetic resonance, neuropsychological examination and periprocedural transcranial Doppler measurement.

Conditions

Interventions

TypeNameDescription
PROCEDUREThoracoscopic Atrial fibrillation AblationAfter blunt dissection of the oblique and transverse sinus, an AtriCure Lumitip Dissector was introduced around the pulmonary veins. Pulmonary vein isolation was achieved with an AtriCure Isolator Synergy ablation clamp around the pulmonary vein antrum at least six times for each side. Ganglionated plexus identification and ablation were performed using an AtriCure Synergy ablation pen. The additional superior and inferior ablation lines connecting the bilateral pulmonary vein isolations were created by applying the AtriCure Synergy ablation pen. Following completion of the ablation on the right side, ablation on the left side was accomplished in a similar manner. The ligament of Marshall was dissected by electrical cautery. Conduction block was confirmed upon completion of the ablation procedure on the left side.

Timeline

Start date
2012-01-01
Primary completion
2019-12-31
Completion
2020-02-01
First posted
2020-05-22
Last updated
2020-05-22

Source: ClinicalTrials.gov record NCT04398979. Inclusion in this directory is not an endorsement.